The tumor vaccine multi‐epitope Peptibody with bFGF/VEGFA we developed showed significant inhibitory effects on tumor progression and angiogenesis in vivo and vitro experiments, which might be used as a potential therapeutic vaccine for tumor treatment. Here, FGF2 is linked to neoplasm.